Search for: "Novartis Pharmaceuticals Corp."
Results 81 - 100
of 366
Sorted by Relevance
|
Sort by Date
9 Aug 2022, 5:53 pm
Corp. v. [read post]
6 Oct 2010, 7:46 am
SmithKlein Beecham Corp., 2010 WL 396300, at *1-2 (D.Ariz. [read post]
22 Oct 2009, 4:05 pm
Stevens, 57, of Missoula filed suit against Novartis Pharmaceuticals Corp., alleging the company should have disclosed health risks associated with the bone-strengthening drug called Zometa. [read post]
15 Apr 2019, 7:19 pm
Timing of Estoppel Unimportant Last week in Novartis Pharmaceutical Corp. v. [read post]
7 Nov 2019, 8:10 pm
Notable advances include Takeda (up 142% based in part on its Shire acquisition, and jumping in the rankings from 23rd to 17th Q4 2018 – Q1 2019), with several other companies showing robust growth (including Celgene Corp., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
21 Jun 2022, 2:18 pm
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. v. [read post]
29 Nov 2011, 7:23 pm
SmithKline Beecham Corp., a significant case concerning pharmaceutical sales representatives. [read post]
21 Jun 2012, 8:43 am
SmithKline Beecham Corp. [read post]
13 Jan 2018, 8:00 pm
American Home Products Corp. [read post]
18 Jul 2012, 12:49 pm
Novartis Pharmaceuticals Corp., No Civ-05-913-L, slip op. [read post]
13 Dec 2017, 9:59 pm
By Kevin E. [read post]
2 Oct 2007, 4:08 am
Novartis Pharmaceuticals Corp. , --- F.R.D. ----, 2007 WL 2197800 (S.D.N.Y., July 31, 2007) (NO. 04 CIV 9194 GEL):Certification under Rule 23(b)(2) is appropriate where "(1) the positive weight or value to the plaintiffs of the injunctive or declaratory relief sought is predominant even though compensatory or punitive damages are also claimed, and (2) class treatment would be efficient and manageable, thereby achieving an appreciable measure of judicial economy. [read post]
14 Mar 2011, 9:25 pm
Two pharmaceutical giants - Novartis Pharmaceuticals and Schering Corp - may have exhausted their legal remedies to fight the Second Circuit's decision. [read post]
12 Jun 2011, 9:17 pm
• Defendants: IntelliPharmaCeutics Corp.; IntelliPharmaCeutics Ltd.; Par Pharmaceutical Inc. [read post]
19 Nov 2010, 11:40 am
Novartis Pharmaceuticals Corp., 06-CV-000149, U.S. [read post]
12 Apr 2017, 8:44 am
Mentor Graphics Corp., 814 F.3d 1309, 1322 (Fed. [read post]
7 Nov 2012, 11:58 am
A jury is ordering Novartis Pharmaceuticals Corp. to pay plaintiff Barbara Davids $10.45 million for osteonecrosis of the jaw injuries she says she sustained because she took the drug Zometa. [read post]
11 Mar 2011, 8:09 am
On February 28, 2011, the United States Supreme Court denied the petition by Novartis and Schering Corp. to review the decision. [read post]
21 Sep 2010, 7:09 pm
Novartis Pharmaceuticals Corp., the jury awarded $250 million in punitive damages. [read post]
5 Dec 2011, 8:59 am
SmithKline Beecham Corp., for example, rejected the argument that pharmaceutical sales representatives did not qualify for the Outside Sales exemption. [read post]
